Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Cell-bound complement activation products associate with lupus severity in SLE.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cell-bound complement activation products associate with lupus severity in SLE.
Cell-bound complement activation products associate with lupus severity in SLE. Lupus Sci Med. 2020 04; 7(1).
View in:
PubMed
subject areas
Adolescent
Adolescent
Adult
Adult
B-Lymphocytes
B-Lymphocytes
Case-Control Studies
Case-Control Studies
Complement Activation
Complement Activation
Complement C3
Complement C3
Complement C4
Complement C4
Cross-Sectional Studies
Cross-Sectional Studies
Erythrocytes
Erythrocytes
Female
Female
Flow Cytometry
Flow Cytometry
Humans
Humans
Immunosuppressive Agents
Immunosuppressive Agents
Lupus Erythematosus, Systemic
Lupus Erythematosus, Systemic
Male
Male
Middle Aged
Middle Aged
Severity of Illness Index
Severity of Illness Index
Young Adult
Young Adult
authors with profiles
Cristina Arriens
Judith A James